InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: NNVClover post# 38789

Sunday, 10/03/2010 3:38:51 PM

Sunday, October 03, 2010 3:38:51 PM

Post# of 146240
They aren't in Phase III. They have been cleared for Phase III, but have not yet started. That is clearly stated in all your links. As of May 2010 they still were not recruiting.

Estimated Enrollment: 715
Study Start Date: October 2010
Estimated Study Completion Date: October 2012
Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)

Detailed Description:

All subjects will receive 3 doses of their assigned vaccine or placebo and will provide blood samples at defined timepoints for flavivirus status and immunogenicity assessment. Reactogenicity data will be collected in all subjects after each dose and throughout the study.


It takes 3 doses over 18 months to load the vaccine, then another 6 months for final bloodwork and data collection. And, that's only for the first 715 of 15K to be tested.

By the way, a nanoviricide® is not a vaccine. It is a treatment and is administered in the field at the point of outbreak and ahead of an infection wave.

doc.feelgoode@yahoo.com

"It ain't what they call you, it's what you answer to." --WC Fields


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News